Dr. Lal PathLabs announced that the 30th Annual General Meeting(AGM) of the company will be held on 29 June 2024.Powered by Capital Market - Live News

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 10 May 2024, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

The Board of Dr Lal Pathlabs at its meeting held on 10 May 2024 has approved the allotment of 2,500 equity shares under ESOP. Pursuant to the above allotment, the paid-up equity share capital of the Company increased to Rs 83,48,03,520/- divided into 8,34,80,352 equity shares of Rs 10/- each.Powered by Capital Market - Live News

Net profit of Dr Lal Pathlabs rose 49.03% to Rs 84.50 crore in the quarter ended March 2024 as against Rs 56.70 crore during the previous quarter ended March 2023. Sales rose 11.08% to Rs 545.40 crore in the quarter ended March 2024 as against Rs 491.00 crore during the previous quarter ended March 2023.For the full year,net profit rose 49.73% to Rs 357.70 crore in the year ended March 2024 as against Rs 238.90 crore during the previous year ended March 2023. Sales rose 10.40% to Rs 2226.60 crore in the year ended March 2024 as against Rs 2016.90 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales545.40491.00 11 2226.602016.90 10 OPM %26.5323.54 -27.3624.29 - PBDT156.50120.80 30 649.10494.10 31 PBT119.9083.20 44 505.50343.90 47 NP84.5056.70 49 357.70238.90 50 Powered by Capital Market - Live News

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News